Because theyre dietary supplementsnot medicationstheres no standardized dosing or clinically established protocol for using them to influence GLP-1
Novo Nordisk's Oral GLP-1/Amylin Weight Loss Drug Novo Nordisk's first-in-class GLP-1/amylin dual agonist 13.1% weight loss as a daily pill in 12 weeks, 22% as a weekly injection in 36 weeks
GLP-1s influence metabolism, mitochondrial function, and inflammation
The medications unique molecular structure allows it to remain active in the bloodstream for approximately one week, making it convenient for patients who prefer weekly rather than daily injections
The entire purpose of a control group is to isolate the supplement's effect from the natural effects of being in a study, receiving attention, and knowing your weight is being tracked
We understand that weight gain often involves more than just diet and exercisewhether youre dealing with hormonal imbalances, metabolic challenges, or chronic fatigue, we take a clinical approach that works with your body to help you succeed